🟡 Medium ImpactPharma
Morepen starts commercial supplies under ₹825 Cr CDMO mandate
Morepen starts commercial supplies under ₹825 Cr CDMO mandate. The company has commenced commercial-scale deliveries under a ₹825 crore CDMO agreement, marking a key milestone in its contract development and manufacturing business. This order strengthens its revenue visibility and operational scale in the pharma export segment.
📊 STOCKS: MOREPENLAB | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #CDMO
#CDMO#OrderWin#Pharma
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Next article
apna mart aims to raise 120 →Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →